Also Read | Regulations won’t derail long-term growth of mutual funds, wealth managers, says Kotak’s Pratik Gupta
Tirumalai highlighted valuation concerns as a major factor behind UBS’s cautious stance. “Historically, India used to trade at a 35–40% premium to other emerging markets. Now, even after a year of underperformance, it’s still at a 60% plus premium,” he said. From a global investor’s perspective, he added, India remains “conspicuously absent” from the AI theme that is driving growth in other markets.
He also pointed to India’s active primary market as one reason for the secondary market’s muted performance. The surge in initial public offerings (IPOs) has absorbed a larger portion of household investment flows. “Corporate demand for equity capital… that number is touching 25% [of household flows],” he said, compared with around 10% before the pandemic.Also Read | Arvind Sanger: AI boom not a bubble yet, India missing out on opportunity
Despite these concerns, Tirumalai ruled out a sharp decline in Indian stocks. UBS expects global equities to remain broadly positive, which should limit India’s downside. “It would be very difficult for the Indian market to correct by more than 5%,” he said, describing the current phase as a “time correction.”
Strong domestic participation continues to provide stability to Indian equities. “That’s a fantastic buffer for the market. It makes it very defensive and very protected against a big correction,” Tirumalai said. He added that UBS expects the Indian rupee to depreciate through the end of next year.
For the full interview, watch the accompanying video
Catch all the latest updates from the stock market here

